Cefdinir
- Product NDC
- 68071-2683
- 11-digit product format
- 680712683
- Labeler code
- 68071
- Product ID
- 68071-2683_ddbdb94c-509f-d65b-e053-2a95a90afec7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cefdinir
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA210534
- Marketing category
- ANDA
- Marketing start
- 2021-02-20
- Marketing end
- 0000-00-00
- Substance
- CEFDINIR
- Active strength
- 250 mg/5mL
- Pharmacologic classes
- Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68071-2683-1 | Cefdinir | 100 mL in 1 BOTTLE | POWDER, FOR SUSPENSION | 100 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68071-2683 | CEFDINIR POWDER, FOR SUSPENSION [NUCARE PHARMACEUTICALS,INC.] | 1 | Legacy NDC, 1 package rows | 20220429_ddbdb94c-509e-d65b-e053-2a95a90afec7.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68071-2683-1 | 68071268301 | 100 mL in 1 BOTTLE (68071-2683-1) | 100 ml | 2022-04-28 | 0000-00-00 | No | No | Current |